RoscoeBradyMD

Psychiatry • Boston, MA

Assistant Professor, Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School

Join to view full profile

Dr. Brady is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brady's full profile

Already have an account?

Office
Beth-Israel Deaconess Medical Center
330 Brookline Aave.
Boston, MA 02215
Phone+1 617-754-1261

Education & Training

Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 2006 - 2010
Columbia University Vagelos College of Physicians and SurgeonsClass of 2006

Certifications & Licensure

MA State Medical License 2008 - 2025
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia Start of enrollment: 2019 May 02
Completed
Not Applicable

Publications & Presentations

PubMed

Cerebellar-Prefrontal Connectivity Predicts Negative Symptom Severity Across the Psychosis Spectrum.
Sean A Yarrell, Sophia H Blyth, Baxter P Rogers, Anna Huang, Alexandra B Moussa-Tooks
Biorxiv. 2024-11-08
Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
Melissa Hwang, Roscoe Brady
The American Journal of Psychiatry. 2024-10-01
Dynamic intervention-based biomarkers may reduce heterogeneity and motivate targeted interventions in clinical high risk for psychosis.
M A Niznikiewicz, R O Brady, S Whitfield-Gabrieli, M S Keshavan, T Zhang
Schizophrenia Research. 2022-08-01

Press Mentions

In the Brain’s Cerebellum, a New Target for Suppressing HungerNovember 18th, 2021